4.6 Review

The Sex Bias of Cancer

期刊

TRENDS IN ENDOCRINOLOGY AND METABOLISM
卷 31, 期 10, 页码 785-799

出版社

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2020.07.002

关键词

-

资金

  1. Portuguese Foundation for Science and Technology (FCT) [PTDC/BIM-ONC/7121/2014, UID/Multi/00709/2013, UID/Multi/00709/2019]
  2. CENTRO 2020 [POCI-01-0145-FEDER-016822]
  3. Lisboa 2020 project grant [POCI-01-0145-FEDER-016822]
  4. Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the Operational Programme for Competitiveness and Internationalization (POCI) COMPETE 2020 in Axis I - Strengthening research, technological development, and innovation [POCI-01-0145-FEDER-007491]
  5. Programa Operacional do Centro, CENTRO 2020 through funding of the ICON project (Interdisciplinary Challenges on Neurodegeneration) [CENTRO-01-0145-FEDER-000013]

向作者/读者索取更多资源

In hormone-dependent organs, sex hormones and dysregulated hormone signaling have well-documented roles in cancers of the breast and female reproductive organs including endometrium and ovary, as well as in prostate and testicular cancers in males. Strikingly, epidemiological data highlight significant differences between the sexes in the incidence of various cancers in nonreproductive organs, where the role of sex hormones has been less well studied. In an era when personalized medicine is gaining recognition, understanding the molecular, cellular, and biological differences between men and women is timely for developing more appropriate therapeutic interventions according to gender. We review evidence that sex hormones also shape many of the dysregulated cellular and molecular pathways that lead to cell proliferation and cancer in nonreproductive organs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据